Frank D. Lee - 02 Jan 2026 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
02 Jan 2026
Net transactions value
-$226,793
Form type
4
Filing time
06 Jan 2026, 17:30:37 UTC
Previous filing
22 Aug 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Frank D. Chief Executive Officer, Director C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUTE 900, BRISBANE /s/ Kristen Williams, Attorney-in-Fact 06 Jan 2026 0001814686

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability $226,793 -9,272 -2.1% $24.46 440,501 02 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
F2 Includes 1,363.841 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025.